Erythromycin Capsule, Delayed Release Pellets
Product Images NDC 75907-076

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 75907-076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Labratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Eryc 01)

FDA Label Image

Pdp-250mg Capsule Bottle Label (Eryc 02)

Pdp-250mg Capsule Bottle Label (Eryc 02)
This text provides information about Erythromycin Delayed-Release Capsules, USP 250 mg. It includes details on the usual adult dosage, storage instructions, and the manufacturer (Dr. Reddy's Laboratories, Inc.). The capsules contain enteric-coated pellets of 250 mg erythromycin base. It is advised to keep the medication out of reach of children, store it in a light-resistant container at room temperature, and protect it from light, moisture, and heat.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.